Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5467]

FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions

FDA approves selpercatinib for lung and thyroid cancers with RET gene mutations or fusions

FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers

FDA approves olaparib plus bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal...

New therapeutic targets for infertility and cancer revealed

New therapeutic targets for infertility and cancer revealed

FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer

FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer

Activating an oestrogen receptor can stop pancreatic cancer cells from growing

Activating an oestrogen receptor can stop pancreatic cancer cells from growing

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj for multiple myeloma

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

FDA approves niraparib for first-line maintenance of advanced ovarian cancer

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with cabozantinib in previously untreated advanced renal cell carcinoma

Positive topline results from pivotal phase 3 CheckMate -9ER trial evaluating nivolumab in combination with...

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

Researchers' method holds promise for brain study, better tests for viruses and brain cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

AACR 2020: Study shows immunotherapy prior to surgery may help destroy high-risk breast cancer

More from ecancer